District of Columbia Code
Subchapter II - Access to Treatment for Anaphylaxis
§ 7–2381.07. Incident reports

(a) An authorized entity that acquires and provides or administers epinephrine auto-injectors shall submit to the Department, on a form developed by the Department, a report of each incident on the authorized entity's premises that involves the provision or administration of an epinephrine auto-injector pursuant to § 7-2381.03.
(b) By January 1, 2020, and annually thereafter, the Department shall publish a report summarizing and analyzing the reports submitted pursuant to subsection (a) of this section during the previous fiscal year.
(Feb. 22, 2019, D.C. Law 22-207, § 8, 65 DCR 12365.)
Applicability of D.C. Law 22-207: § 7155 of D.C. Law 23-16 repealed § 10 of D.C. Law 22-207. Therefore the creation of this section by D.C. Law 22-207 has been implemented.
Applicability of D.C. Law 22-207: § 10 of D.C. Law 22-207 provided that the creation of this section by § 8 of D.C. Law 22-207 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.
For temporary (90 days) repeal of applicability provision of D.C. Law 22-207, see § 7155 of Fiscal Year 2020 Budget Support Congressional Review Emergency Act of 2019 (D.C. Act 23-112, Sept. 4, 2019, 66 DCR 11964).
For temporary (90 days) repeal of applicability provision of D.C. Law 22-207, see § 7155 of Fiscal Year 2020 Budget Support Emergency Act of 2019 (D.C. Act 23-91, July 22, 2019, 66 DCR 8497).

Structure District of Columbia Code